Chronic Thromboembolic Pulmonary Hypertension Incidence, Post-pulmonary Embolism Syndrome and Possible Role of Transcatheter Therapy in Prevention
Authors:
- Belén Biscotti RodilBRBelén Biscotti Rodil
- Juan Duarte TorresJTJuan Duarte Torres
- Irene Martín de MiguelIMIrene Martín de Miguel
- Alejandro Cruz UtrillaAUAlejandro Cruz Utrilla
- Nicolás Maneiro MelónNMNicolás Maneiro Melón
- Jorge Nuche BerenguerJorge Nuche Berenguer
- Yolanda Revilla OstolazaYOYolanda Revilla Ostolaza
- Sergio Alonso CharterinaSCSergio Alonso Charterina
- María Jesús López GudeMGMaría Jesús López Gude
- Carmen Jiménez López-GuarchCLCarmen Jiménez López-Guarch
- Fernando Arribas YnsaurriagaFYFernando Arribas Ynsaurriaga
- Pilar Escribano SubíasPSPilar Escribano Subías
Open Access
- 17 December 2025
- journal article
- Published by Radcliffe Medical Media Ltd in Interventional Cardiology: Reviews, Research, Resources
- Vol. 20
Abstract
Pulmonary embolism (PE) presents both acute and chronic complications that significantly affect patient outcomes. Acute complications include syncope or sudden death, often resulting from severe hypoxaemia or right ventricular failure; and early recurrence of the embolic event. Chronic complications, which can develop over time, are often grouped under post-embolic syndrome (PES), a condition affecting more than half of PE survivors. Symptoms of PES include persistent dyspnoea and reduced exercise tolerance. PES is associated with several serious conditions, such as chronic thromboembolic pulmonary hypertension, chronic thromboembolic pulmonary disease, right ventricular dysfunction, physical deconditioning, and psychological harm. Although promising catheter-directed therapies are under investigation for acute PE treatment, their effectiveness in preventing chronic complications has yet to be confirmed by large-scale randomised controlled trials.Keywords
This publication has 53 references indexed in Scilit:
- Chronic Thromboembolic Pulmonary HypertensionJAMA, 2024
- Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2Clinical Research in Cardiology, 2022
- Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary EmbolismJAMA Cardiology, 2022
- Post Pulmonary Embolism SyndromeArchivos de Bronconeumología, 2022
- Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO studyAmerican Heart Journal, 2022
- Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary HypertensionClinics in Chest Medicine, 2021
- The psychological impact of pulmonary embolism: A mixed‐methods studyResearch and Practice in Thrombosis and Haemostasis, 2021
- Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Embolism After Short Duration of Anticoagulation TherapyThe American Journal of the Medical Sciences, 2020
- Detection of Exercise‐Induced Pulmonary Arterial Hypertension by Cardiopulmonary Exercise TestingClinical Cardiology, 2012
- Clinical Characteristics of Patients with Acute Pulmonary Embolism: Data from PIOPED IIThe American Journal of Medicine, 2007